Welcome

NEURONAX is a privately-held biopharmaceutical company focusing on the development and discovery of therapeutic approaches to treat central nervous system disorders.

Combining an expertise in the development of candidate-drugs and know-how in cell-based assays, NEURONAX builds a well balanced portfolio of compounds and technologies implied in neurorepair. Moreover, the original platform of NEURONAX allows the enrichment of its portfolio of products and is also proposed outside in the form of contracts of service or contracts of research.

NEURONAX aims at forming strategic alliances with partners and establishes preclinical "proof-of-concept" and out-licenses agreements with biotechnology and pharmaceutical companies.